“…The number of studies that reported the association of current antibiotic use, skin lesions, intravenous device use, current trimethoprim-sulfamethoxazole (TMP-SMX) use, and an MRSA colonization history with the risk of MRSA colonization and infection was three, four, four, eight, and 27,32,34,36,[38][39][40][41][42][44][45][46][47][48][49]52,53,56 six, respectively (Figure 10). [26][27][28][29][32][33][34][35]37,38,40,47,48,51,55 Skin lesions (OR 2.02; 95% CI 1.15, 3.55; P ¼ 0.015), intravenous device use (OR 2.61; 95% CI 1.59, 4.29; P < 0.001) and an MRSA colonization history (OR 6.30; 95% CI 2.50, 15.90; P < 0.001) were associated with an increased risk of MRSA colonization and infection, whereas the current use of antibiotics was associated with a reduced risk of MRSA colonization and infection (OR 0.13; 95% CI 0.05, 0.32; P < 0.001).…”